Rekha Hemrajani - Net Worth and Insider Trading
Rekha Hemrajani Net Worth
The estimated net worth of Rekha Hemrajani is at least $4,530 dollars as of 2024-11-29. Rekha Hemrajani is the Director of ALX Oncology Holdings Inc and owns about 3,000 shares of ALX Oncology Holdings Inc (ALXO) stock worth over $4,530. Details can be seen in Rekha Hemrajani's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rekha Hemrajani has not made any transactions after 2020-07-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rekha Hemrajani
Rekha Hemrajani Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rekha Hemrajani owns 6 companies in total, including ALX Oncology Holdings Inc (ALXO) , Adverum Biotechnologies Inc (ADVM) , and Aravive Inc (ARAV) among others .
Click here to see the complete history of Rekha Hemrajani’s form 4 insider trades.
Insider Ownership Summary of Rekha Hemrajani
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALXO | ALX Oncology Holdings Inc | 2020-07-21 | director |
| ADVM | Adverum Biotechnologies Inc | 2019-05-01 | director |
| ARAV | Aravive Inc | 2020-01-09 | director & President and CEO |
 | | 2019-03-25 | See Remarks |
| | 2021-07-29 | director |
| | 2020-11-18 | director & Chief Executive Officer |
Rekha Hemrajani Latest Holdings Summary
Rekha Hemrajani currently owns a total of 1 stock. Rekha Hemrajani owns 3,000 shares of ALX Oncology Holdings Inc (ALXO) as of July 21, 2020, with a value of $4,530.
Latest Holdings of Rekha Hemrajani
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXO | ALX Oncology Holdings Inc | 2020-07-21 | 3,000 | 1.51 | 4,530 |
Holding Weightings of Rekha Hemrajani
Rekha Hemrajani Form 4 Trading Tracker
According to the SEC Form 4 filings, Rekha Hemrajani has made a total of 1 transactions in ALX Oncology Holdings Inc (ALXO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in ALX Oncology Holdings Inc is the acquisition of 3,000 shares on July 21, 2020, which cost Rekha Hemrajani around $57,000.
Insider Trading History of Rekha Hemrajani
- 1
Rekha Hemrajani Trading Performance
GuruFocus tracks the stock performance after each of Rekha Hemrajani's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rekha Hemrajani is 38.74%. GuruFocus also compares Rekha Hemrajani's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rekha Hemrajani within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rekha Hemrajani's insider trading performs compared to the benchmark.
Performance of Rekha Hemrajani
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 46.47 | | | | | |
| Relative Return to S&P 500(%) | 42.18 | | | | | |
Rekha Hemrajani Ownership Network
Rekha Hemrajani Owned Company Details
What does ALX Oncology Holdings Inc do?
Who are the key executives at ALX Oncology Holdings Inc?
Rekha Hemrajani is the director of ALX Oncology Holdings Inc. Other key executives at ALX Oncology Holdings Inc include VP & Finance and CAO Shelly Pinto , Chief Medical Officer Sophia Randolph , and director & President and CEO Jaume Pons .
ALX Oncology Holdings Inc (ALXO) Insider Trades Summary
Over the past 18 months, Rekha Hemrajani made no insider transaction in ALX Oncology Holdings Inc (ALXO). Other recent insider transactions involving ALX Oncology Holdings Inc (ALXO) include a net sale of 145,903 shares made by Jaume Pons , a net sale of 14,288 shares made by Shelly Pinto , and a net sale of 18,243 shares made by Sophia Randolph .
In summary, during the past 3 months, insiders sold 0 shares of ALX Oncology Holdings Inc (ALXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 179,321 shares of ALX Oncology Holdings Inc (ALXO) were sold and 28,400 shares were bought by its insiders, resulting in a net sale of 150,921 shares.
ALX Oncology Holdings Inc (ALXO)'s detailed insider trading history can be found in Insider Trading Tracker table.
ALX Oncology Holdings Inc Insider Transactions
Rekha Hemrajani Mailing Address
Above is the net worth, insider trading, and ownership report for Rekha Hemrajani. You might contact Rekha Hemrajani via mailing address: 3928 Point Eden Way, Hayward Ca 94545.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
